top of page
News, Events and Updates
Search
Anavex Life Sciences to Initiate Phase 2 Study of ANAVEX®2-73 in Parkinson's Disease Dementia
Apr 16, 2018
Anavex Life Sciences to Present at the 30th Annual ROTH Conference
Mar 9, 2018
Anavex Life Sciences to Present New Preclinical Data at the 20th Annual Meeting of the ASENT
Mar 7, 2018
Anavex Life Sciences to Present at Cowen and Company 38th Annual Health Care Conference
Mar 6, 2018
Anavex Life Sciences Strengthens Management Team and Board of Directors
Mar 5, 2018
Anavex Life Sciences to Present at the 2018 BIO CEO & Investor Conference
Feb 8, 2018
Anavez Life Sciences Provides Clinical Programs Update and Reports Fiscal First Quarter 2018 Results
Feb 7, 2018
Anavex Life Sciences to Announce Fiscal First Quarter 2018 Results and Update on Clinical Programs
Feb 5, 2018
Anavex Life Sciences to Present at the Noble Capital Markets 14th Annual Institutional Conference
Jan 24, 2018
Anavex Life Sciences Reports Potential Normalization of Hypertension with ANAVEX®2-73
Jan 16, 2018
36th Annual J.P. Morgan Healthcare Conference in San Francisco on January 8th-11th
Jan 8, 2018
22
23
24
25
26
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
